Immune cell topography of head and neck cancer

被引:3
|
作者
Muijlwijk, Tara [1 ,2 ,3 ]
Nijenhuis, Dennis N. L. M. [1 ,2 ,3 ]
Ganzevles, Sonja H. [1 ,2 ,3 ]
Ekhlas, Fatima [1 ,2 ,3 ]
Ballesteros-Merino, Carmen [4 ]
Peferoen, Laura A. N. [2 ,5 ,6 ]
Bloemena, Elisabeth [2 ,5 ,6 ]
Fox, Bernard A. [4 ]
Poell, Jos B. [1 ,2 ]
Leemans, C. Rene [1 ,2 ]
Brakenhoff, Ruud H. [1 ,2 ]
van de Ven, Rieneke [1 ,2 ,3 ]
机构
[1] Amsterdam UMC Locatie VUmc, Otolaryngol Head & Neck Surg, Amsterdam, Netherlands
[2] Canc Ctr Amsterdam, Canc Biol & Immunol, Amsterdam, Netherlands
[3] Amsterdam Inst Immunol & Infect Dis, Canc Immunol, Amsterdam, Netherlands
[4] Earle A Chiles Res Inst, Providence Canc Ctr, Robert W Franz Canc Res Ctr, Mol & Tumor Immunol Lab, Portland, OR USA
[5] Amsterdam UMC Locatie VUMC, Pathol, Amsterdam, Netherlands
[6] Acad Ctr Dent Amsterdam, Maxillofacial Surg Oral Pathol, Amsterdam, Netherlands
关键词
B cell; Head and Neck Cancer; Macrophage; T cell; Tumor microenvironment - TME; HUMAN-PAPILLOMAVIRUS; TUMOR; CARCINOMA; SURVIVAL; LARYNX; MICROENVIRONMENT; HYPOPHARYNX; HPV;
D O I
10.1136/jitc-2024-009550
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Approximately 50% of head and neck squamous cell carcinomas (HNSCC) recur after treatment with curative intent. Immune checkpoint inhibitors are treatment options for recurrent/metastatic HNSCC; however, less than 20% of patients respond. To increase this response rate, it is fundamental to increase our understanding of the spatial tumor immune microenvironment (TIME).Methods In total, 53 HNSCC specimens were included. Using a seven-color multiplex immunohistochemistry panel we identified tumor cells, CD163+macrophages, B cells, CD8+T cells, CD4+T helper cells and regulatory T cells (Tregs) in treatment-naive surgical resection specimens (n=29) and biopsies (n=18). To further characterize tumor-infiltrating CD8+T cells, we stained surgical resection specimens (n=12) with a five-color tumor-resident panel including CD103, Ki67, CD8 and pan-cytokeratin. Secretome analysis was performed on matched tumor suspensions (n=11) to measure protein levels.Results Based on CD8+T cell infiltrates, we identified four different immunotypes: fully infiltrated, stroma-restricted, immune-excluded, and immune-desert. We found higher cytokine levels in fully infiltrated tumors compared with other immunotypes. While the highest immune infiltrates were observed in the invasive margin for all immune cells, CD163+macrophages and Tregs had the highest tendency to infiltrate the tumor center. Within the tumor center, especially B cells stayed at the tumor stroma, whereas CD163+macrophages, followed by T cells, were more often localized within tumor fields. Also, B cells were found further away from other cells and often formed aggregates while T cells and CD163+macrophages tended to be more closely located to each other. Across resection specimens from various anatomical sites within the head and neck, oral cavity tumors exhibited the highest densities of Tregs. Moreover, the distance from B cells and T cells to tumor cells was shortest in oral cavity squamous cell carcinoma (OCSCC), suggesting more interaction between lymphocytes and tumor cells. Also, the fraction of T cells within 10 mu m of CD163+macrophages was lowest in OCSCC, indicating fewer myeloid/T-cell suppressive interactions in OCSCC.Conclusions We comprehensively described the TIME of HNSCC using a unique data set of resection specimens. We discovered that the composition, as well as the relative localization of immune cells in the TIME, differed in distinct anatomical sites of the head and neck.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] mTOR, metabolism, and the immune response in HPV-positive head and neck squamous cell cancer
    Coppock Joseph D
    Lee John H
    世界耳鼻咽喉头颈外科杂志(英文), 2016, 2 (02)
  • [32] TILling head and neck cancer for cell therapy
    Gottschalk, Stephen
    CYTOTHERAPY, 2011, 13 (07) : 772 - 773
  • [33] Immunotherapy in Head and Neck Squamous Cell Cancer
    Denaro, Nerina
    Merlano, Marco Carlo
    CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY, 2018, 11 (04) : 217 - 223
  • [34] Cetuximab and the Head and Neck Squamous Cell Cancer
    Concu, Riccardo
    Cordeiro, M. Natalia D. S.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (03) : 192 - 198
  • [35] Cell surface targets in head and neck cancer
    Kondratyev, Maria
    Pesic, Aleksandra
    Sayad, Azin
    Ketela, Troy
    Stickle, Natalie
    Virtanen, Carl
    Moffat, Jason
    Ailles, Laurie
    Koritzinsky, Marianne
    Wouters, Brad
    CANCER RESEARCH, 2019, 79 (13)
  • [36] Progression of head and neck squamous cell cancer
    József Tímár
    Orsolya Csuka
    Éva Remenár
    Gábor Répássy
    Miklós Kásler
    Cancer and Metastasis Reviews, 2005, 24 : 107 - 127
  • [37] mTOR, metabolism, and the immune response in HPV-positive head and neck squamous cell cancer
    Coppock Joseph D.
    Lee John H.
    世界耳鼻咽喉头颈外科杂志英文版, 2016, (02) : 76 - 83
  • [38] Dynamics of T-cell-driven immune responses to radiotherapy in a model of head and neck cancer
    Hak, C. M. L. Chan Wah
    Baldock, H.
    Appleton, E.
    Hassan, J.
    Pedersen, M.
    Ono, M.
    Harrington, K. J.
    Melcher, A.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S201 - S202
  • [39] Influence of photodynamic therapy on peripheral immune cell populations and cytokine concentrations in head and neck cancer
    Theodoraki, M. N.
    Lorenz, K.
    Lotfi, R.
    Fuerst, D.
    Tsamadou, C.
    Jaekle, S.
    Mytilineos, J.
    Brunner, C.
    Theodorakis, J.
    Hoffinann, T. K.
    Laban, S.
    Schuler, P. J.
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2017, 19 : 194 - 201
  • [40] Reappraisal of metastatic lymph node topography in head and neck squamous cell carcinomas
    Tao, Lei
    Lefevre, Marine
    Callard, Patrice
    Perie, Sophie
    Bernaudin, Jean-Francois
    St Guily, Jean Lacau
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2006, 135 (03) : 445 - 450